This Website uses cookies to provide you with a personalized browsing experience. By using this Website, you agree to our use of cookies as explained in our Privacy Policy. Please read our Privacy Policy for more information on how we use cookies and how you can manage them.

Formulation Development

  • Formulation pipeline has 250+ complex products where >75% is development for International markets majorly in Respiratory, Oncology, ARVs, Ophthalmology, CNS, CVS etc.
  • Cipla’s development lab is equipped with state-of-the-art infrastructure for development of innovative technology products.
  • Cipla develops and applies skills to ensure the quality of its products right from the design to the manufacturing stage safeguarding patients’ safety and efficacy of the products.
  • The development process for the products followed, ensures formulation development based on Quality by Design (QBD) principles enabling robust, reproducible and regulatory complied products in the market.